MVIS vs INVZ

For growth investors, Innoviz Technologies Ltd.

(INVZ) is the stronger pick with 127. 0% revenue growth year-over-year, versus -74. 3% for MicroVision, Inc. (MVIS). Analysts rate MicroVision, Inc. (MVIS) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Innoviz Technologies Ltd.

(INVZ) delivered a total return of -93. 0%, compared to -95. 6% for MicroVision, Inc. (MVIS). Over 10 years, the gap is even starker: MVIS returned -66. 2% versus INVZ's -92. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), MicroVision, Inc.

(MVIS) is the lower-risk stock at 2. 61β versus Innoviz Technologies Ltd. 's 2. 69β — meaning INVZ is approximately 3% more volatile than MVIS relative to the S&P 500. On balance sheet safety, MicroVision, Inc. (MVIS) carries a lower debt/equity ratio of 66% versus 83% for Innoviz Technologies Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Innoviz Technologies Ltd.

(INVZ) is pulling ahead at 127. 0% versus -74. 3% for MicroVision, Inc. (MVIS). On earnings-per-share growth, the picture is similar: Innoviz Technologies Ltd. grew EPS 40. 4% year-over-year, compared to 23. 9% for MicroVision, Inc.. Over a 3-year CAGR, INVZ leads at 109. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Innoviz Technologies Ltd.

(INVZ) is the more profitable company, earning -123. 1% net margin versus -78. 6% for MicroVision, Inc. — meaning it keeps -123. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVZ leads at -123. 0% versus -57. 4% for MVIS. At the gross margin level — before operating expenses — INVZ leads at 23. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, MicroVision, Inc.

(MVIS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Innoviz Technologies Ltd. (INVZ) carries a higher beta of 2. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MVIS: -66. 2%, INVZ: -92. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MVIS (Technology) and INVZ (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MVIS is a small-cap quality compounder stock; INVZ is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.